OBJECTIVE- To study the prevalence of and risk factors for abnormal glucose tolerance in transfusion-dependent beta- thalassemic patients. RESEARCH DESIGN AND METHODS- A total of 89 transfusion-dependent beta- thalassemic patients were interviewed. Diabetes was previously diagnosed in 14 of them . In the remaining 75 patients, 68 participated in an oral glucose tolerance test. Potential risk factors were identified using the independent t test, X2 test, and Fisher 's exact test. Logistic regression analysis was used to select the independent risk factors that best predicted abnormal glucose tolerance. A two-tailed P value of <0.05 was considered to be statistically significant. RESULTS- The prevalence of impaired glucose tolerance was 8.5% ...
Iron overload in patients with thalassemia major (TM) affects glucose regulation, and is mediated by...
Background: Iron chelation therapy (ICT) is the gold standard for treating patients with iron over-l...
Beta thalassemia is the most common genetic blood disease, affecting millions of people in both deve...
Objectives: To evaluate the impaired glucose metabolism and their possible risk factors in beta thal...
Background: Diabetes is one of the most common endocrine disorder worldwide that due to high prevale...
Objectives: To evaluate the impaired glucose metabolism and their possible risk factors in beta thal...
BackgroundDiabetes mellitus is a major endocrinopathy for patients with thalassemia major. Although ...
Background Diabetes mellitus is a common complication in pa- tients with thalassemia major. Iron ove...
Background and Objective: Thalassemia major is a genetic disorder. Blood transfusion is critical for...
Background: Blood transfusion-dependent beta Thalassemia Major (BTM) patients are at risk of hemosid...
Thalassemia is a genetic disorder involving the underproduction of the globin chains of hemoglobin. ...
Objective: The purpose of the research was to judge the regularity of abnormal glucose tolerance in ...
SUMMARY Glucose tolerance tests performed in 15 patients (10 males and 5 females, age range 6-34 yea...
ABSTRACT: Introduction: Β-Thalassemia is a chronic hereditary hemolytic anemia characterized by a d...
Objective: To determine the prevalence and risk factors of hypogonadotropic hypogonadism in transfus...
Iron overload in patients with thalassemia major (TM) affects glucose regulation, and is mediated by...
Background: Iron chelation therapy (ICT) is the gold standard for treating patients with iron over-l...
Beta thalassemia is the most common genetic blood disease, affecting millions of people in both deve...
Objectives: To evaluate the impaired glucose metabolism and their possible risk factors in beta thal...
Background: Diabetes is one of the most common endocrine disorder worldwide that due to high prevale...
Objectives: To evaluate the impaired glucose metabolism and their possible risk factors in beta thal...
BackgroundDiabetes mellitus is a major endocrinopathy for patients with thalassemia major. Although ...
Background Diabetes mellitus is a common complication in pa- tients with thalassemia major. Iron ove...
Background and Objective: Thalassemia major is a genetic disorder. Blood transfusion is critical for...
Background: Blood transfusion-dependent beta Thalassemia Major (BTM) patients are at risk of hemosid...
Thalassemia is a genetic disorder involving the underproduction of the globin chains of hemoglobin. ...
Objective: The purpose of the research was to judge the regularity of abnormal glucose tolerance in ...
SUMMARY Glucose tolerance tests performed in 15 patients (10 males and 5 females, age range 6-34 yea...
ABSTRACT: Introduction: Β-Thalassemia is a chronic hereditary hemolytic anemia characterized by a d...
Objective: To determine the prevalence and risk factors of hypogonadotropic hypogonadism in transfus...
Iron overload in patients with thalassemia major (TM) affects glucose regulation, and is mediated by...
Background: Iron chelation therapy (ICT) is the gold standard for treating patients with iron over-l...
Beta thalassemia is the most common genetic blood disease, affecting millions of people in both deve...